Nieuwe ontwikkelingen in de behandeling van het kortedarmsyndroom bij kinderen
Tóm tắt
Het kortedarmsyndroom wordt veroorzaakt door malabsorptie van macronutriënten, vitaminen en spoorelementen en gaat gepaard met gewichtsverlies. Kinderen met deze aandoening zijn vaak afhankelijk van parenterale voeding, hetgeen weer risico geeft op levensbedreigende complicaties. Aanpassingen in het dieet, maar ook hormoontherapie gericht op de adaptatie van het epitheel, zouden de opnamecapaciteit van de darm kunnen verbeteren, en daarmee afhankelijkheid van parenterale voeding kunnen voorkomen.
Tài liệu tham khảo
Messing B, Pigot F, Rongier M, et al. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology 1991;100:1502-8.
Jeppeson PB, Mortensen PW. Experimental approaches: dietary and hormone therapy. Best Pract Res Clin Gastroenterol 2003;17:1041-54.
Norgard DI, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small bowel failure proceeds. Am J Clin Nutr 1996;64:222-31.
Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998;43:478-83.
Bohane TD, Haka-Ikse K, Biggar WD, et al. A clinical study of young infants after small intestinal resection. J Pediatr 1979;94:552-8.
Briet F, Flourié B, Achour L, et al. Bacterial adaptation in patients with short bowel and colon in continuity. Gastroenterology 1995;109:1446-53.
Marteau P, Messing B, Arrigoni E, et al. Do patients with short-bowel syndrome need a lactose-free diet? Nutrition 1997;13:13-6.
Lifschitz CH. Growth hormone for short bowel adaptation: is less more effective than more? [editorial]. J Pediatr Gastroenterol Nutr 2004;38(1):111-2.
Jeppesen PB, Sanuinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005;54(9):1224-31.
Severijnen RSVM, Swieten ECAM van, Tolboom JJM, et al. Contribution of growth hormone treatment in children with a short small bowel [thesis]. Short small bowel in children. 2004.
Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg 2005;242 (5):655-61.
Lifschitz C, Dugan C, Langston C, et al. Growth hormone therapy in children with short bowel syndrome: a randomized placebo-controlled trial. Gastroenterology 2003;124:A64.
Nucci AM, Finegold DN, Yaworski JA, et al. Results of growth trophic therapy in children with short bowel syndrome. J Pediatr Surg 2004;39(3):335-9.
Sigalet DL, Martin G, Meddings J, et al. GLP-2 levels in infants with intestinal dysfunction. Pediatr Res 2004;56(3):371-6.
Weiming Z, Ning L, Jieshou L. Effect of recombinant human growth hormone and enteral nutrition on short bowel sundrome. JPEN J Parenter Enteral Nutr 2004;28(6):377-81.